India Anti-Fungal Drugs Market Set for Robust Growth Amid Rising Infections and Drug Innovation : 2025–2030
The India Anti-Fungal Drugs Market is experiencing robust growth, driven by the increasing prevalence of fungal infections, expanding healthcare infrastructure, and rising awareness among healthcare professionals and patients. In 2024, the market was valued at USD 11,263.10 million and is projected to reach USD 15,130.62 million by 2030, registering a CAGR of 6.29% during 2025–2030.… Read More »